Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 5—May 2006
Dispatch

Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands

Ed J. Kuijper*Comments to Author , Renate J. van den Berg*, Sylvia Debast†, Caroline E. Visser‡, Dick Veenendaal§, Annet Troelstra¶, Tjallie van der Kooi#, Susan van den Hof#, and Daan W. Notermans#
Author affiliations: *Leiden University Medical Center, Leiden, the Netherlands; †St Jansdal Hospital, Harderwijk, the Netherlands; ‡Academic Medical Center, Amsterdam, the Netherlands; §The Public Health Laboratory, Haarlem, the Netherlands; ¶Utrecht Medical Center, Utrecht, the Netherlands; #National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands

Main Article

Table

Characteristics of 9 hospitals with patients with Clostridium difficile–associated diarrhea due to PCR ribotype 027, toxinotype III*

Hospital no. and setting No. beds Admissions
Incidence/
10,000, before outbreak Maximum incidence/
mo/10,000, during outbreak† Date of outbreak onset Total no. CDAD patients in given period, 2005 Deaths, 30 d No. strains studied No. toxinotype III, PCR ribotype 027 strains
1. Harderwijk 341 4 83 Apr 2005 51, Apr–Nov 3 30 19
2. Amersfoort 600 11 87 May 2005 85, Jan–Dec 19 50 15
3. Utrecht 1,013 16 No outbreak 37, Jun–Dec Unk. 17 6
4. Nieuwegein 584 11 No outbreak 13, Jan–Dec Unk. 4 1
5. Amsterdam 1,002 38 52 June 2005 68, Jan–Oct 1 28 12
6. Amsterdam 310 10 66 Apr–May 2005 42, Jan–Oct Unk. 34 16
7. Haarlem 744 7 27 2004 66, Jan–Dec Unk. 9 7
8. Hoofddorp 455 3 76 Jan 2005 73, Jan–Dec Unk. 8 8
9. Beverwijk 383 4 47 2002 24, Jan–Dec Unk. 4 3

*PCR, polymerase chain reaction; CDAD, Clostridium difficile–associated diarrhea; unk., unknown.
†Timeframe 2–4 mo.

Main Article

Page created: January 12, 2012
Page updated: January 12, 2012
Page reviewed: January 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external